Skip to main content

Penbrook Management LLC

Position in NVO — Novo Nordisk A S

CIK 1381055 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$15,158,628
+$3,538,278 QoQ
Shares Held
316,200
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
10.28%
of 13F equity value
Holder Rank
#121
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Penbrook Management LLC holds $17,922,911 across 5 Drug Manufacturers - General names. NVO ranks #1 (84.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVO
Novo Nordisk A S
This page
316,200 $15,158,628

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,158,628 316,200
2026-03-31 $11,620,350 316,200
2025-12-31 $16,098,432 316,400
2025-09-30 $17,290,684 311,600
2025-06-30 $21,492,828 311,400
2025-03-31 $21,623,616 311,400
2024-12-31 $26,872,648 312,400
2024-09-30 $37,209,375 312,500
2024-06-30 $44,620,524 312,600
2024-03-31 $40,137,840 312,600
2023-12-31 $32,400,540 313,200
2023-09-30 $28,846,168 317,200
2023-06-30 $25,666,238 158,600
2023-03-31 $25,335,088 159,200
2022-12-31 $21,667,934 160,100
2022-09-30 $17,051,674 171,150
2022-06-30 $19,126,959 171,650
2022-03-31 $19,061,732 171,650
2021-12-31 $19,224,800 171,650
2021-09-30 $16,480,116 171,650
2021-06-30 $14,404,251 171,950
2021-03-31 $11,592,869 171,950
2020-12-31 $12,003,722 171,850
2020-09-30 $8,807,195 126,850
2020-06-30 $8,273,398 126,350
2020-03-31 $7,606,270 126,350